Continuous subcutaneous insulin pump therapy is a method of delivering insulin via a small device implanted under the skin, providing a steady supply of insulin to manage blood glucose levels in individuals with diabetes. This approach allows for more precise control of insulin delivery, reducing the risk of hyperglycaemia and hypoglycaemia, and improving overall glycaemic control. A key complication associated with this therapy is the risk of pump malfunction or site infection, which can affect diabetes management.

Please confirm you want to block this member.
You will no longer be able to:
Please allow a few minutes for this process to complete.